Aesthetic Medical International Holdings Group Limited
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China. The company offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and radiofrequency tr… Read more
Aesthetic Medical International Holdings Group Limited (PAIYY) - Total Assets
Latest total assets as of June 2025: $486.50 Million USD
Based on the latest financial reports, Aesthetic Medical International Holdings Group Limited (PAIYY) holds total assets worth $486.50 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Aesthetic Medical International Holdings Group Limited - Total Assets Trend (2020–2024)
This chart illustrates how Aesthetic Medical International Holdings Group Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Aesthetic Medical International Holdings Group Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
Aesthetic Medical International Holdings Group Limited's total assets of $486.50 Million consist of 18.1% current assets and 81.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 8.8% |
| Accounts Receivable | $11.47 Million | 2.4% |
| Inventory | $14.91 Million | 3.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $3.58 Million | 0.7% |
| Goodwill | $33.00 Million | 6.8% |
Asset Composition Trend (2020–2024)
This chart illustrates how Aesthetic Medical International Holdings Group Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aesthetic Medical International Holdings Group Limited's current assets represent 18.1% of total assets in 2024, a decrease from 19.9% in 2020.
- Cash Position: Cash and equivalents constituted 8.8% of total assets in 2024, up from 4.3% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, a decrease from 19.0% in 2020.
- Asset Diversification: The largest asset category is goodwill at 6.8% of total assets.
Aesthetic Medical International Holdings Group Limited Competitors by Total Assets
Key competitors of Aesthetic Medical International Holdings Group Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
Aesthetic Medical International Holdings Group Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Aesthetic Medical International Holdings Group Limited generates 1.55x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Aesthetic Medical International Holdings Group Limited is currently not profitable relative to its asset base.
Aesthetic Medical International Holdings Group Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.24 | 0.24 | 0.21 |
| Quick Ratio | 0.21 | 0.20 | 0.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-300.27 Million | $ -315.49 Million | $ -53.34 Million |
Aesthetic Medical International Holdings Group Limited - Advanced Valuation Insights
This section examines the relationship between Aesthetic Medical International Holdings Group Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.86 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -13.3% |
| Total Assets | $486.22 Million |
| Market Capitalization | $618.35K USD |
Valuation Analysis
Below Book Valuation: The market values Aesthetic Medical International Holdings Group Limited's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Aesthetic Medical International Holdings Group Limited's assets decreased by 13.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Aesthetic Medical International Holdings Group Limited (2020–2024)
The table below shows the annual total assets of Aesthetic Medical International Holdings Group Limited from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $486.22 Million | -13.28% |
| 2023-12-31 | $560.66 Million | +2.62% |
| 2022-12-31 | $546.37 Million | -5.30% |
| 2021-12-31 | $576.94 Million | -44.42% |
| 2020-12-31 | $1.04 Billion | -- |